ESLAW Annual Net Income
-$7.31 M
+$3.80 M+34.21%
30 June 2024
Summary:
As of February 5, 2025, ESLAW annual net profit is -$7.31 million, with the most recent change of +$3.80 million (+34.21%) on June 30, 2024. During the last 3 years, it has fallen by -$6.58 million (-896.56%).ESLAW Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW Quarterly Net Income
-$3.38 M
+$574.34 K+14.54%
30 September 2024
Summary:
As of February 5, 2025, ESLAW quarterly net profit is -$3.38 million, with the most recent change of +$574.34 thousand (+14.54%) on September 30, 2024. Over the past year, it has dropped by -$2.36 million (-230.85%).ESLAW Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW TTM Net Income
-$8.82 M
-$1.51 M-20.60%
30 September 2024
Summary:
As of February 5, 2025, ESLAW TTM net profit is -$8.82 million, with the most recent change of -$1.51 million (-20.60%) on September 30, 2024. Over the past year, it has dropped by -$5.93 million (-205.00%).ESLAW TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | -230.8% | -205.0% |
| 3 y3 years | -896.6% | -230.8% | -205.0% |
| 5 y5 years | -896.6% | -230.8% | -205.0% |
ESLAW Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +896.6% | +619.2% | +219.9% |
Estrella Immunopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.38 M(-14.5%) | -$8.82 M(+20.6%) |
| June 2024 | -$7.31 M | -$3.95 M(+741.5%) | -$7.31 M(+117.6%) |
| Mar 2024 | - | -$469.53 K(-54.0%) | -$3.36 M(+16.2%) |
| Dec 2023 | - | -$1.02 M(-45.4%) | -$2.89 M(-37.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.87 M(-32.1%) | -$4.63 M(+67.9%) |
| June 2023 | -$11.11 M(+559.5%) | - | - |
| Dec 2022 | - | -$2.76 M | -$2.76 M |
| June 2022 | -$1.69 M(+129.7%) | - | - |
| June 2021 | -$733.69 K | - | - |
FAQ
- What is Estrella Immunopharma annual net profit?
- What is the all time high annual net income for Estrella Immunopharma?
- What is Estrella Immunopharma annual net income year-on-year change?
- What is Estrella Immunopharma quarterly net profit?
- What is the all time high quarterly net income for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly net income year-on-year change?
- What is Estrella Immunopharma TTM net profit?
- What is the all time high TTM net income for Estrella Immunopharma?
- What is Estrella Immunopharma TTM net income year-on-year change?
What is Estrella Immunopharma annual net profit?
The current annual net income of ESLAW is -$7.31 M
What is the all time high annual net income for Estrella Immunopharma?
Estrella Immunopharma all-time high annual net profit is -$733.69 K
What is Estrella Immunopharma annual net income year-on-year change?
Over the past year, ESLAW annual net profit has changed by +$3.80 M (+34.21%)
What is Estrella Immunopharma quarterly net profit?
The current quarterly net income of ESLAW is -$3.38 M
What is the all time high quarterly net income for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly net profit is -$469.53 K
What is Estrella Immunopharma quarterly net income year-on-year change?
Over the past year, ESLAW quarterly net profit has changed by -$2.36 M (-230.85%)
What is Estrella Immunopharma TTM net profit?
The current TTM net income of ESLAW is -$8.82 M
What is the all time high TTM net income for Estrella Immunopharma?
Estrella Immunopharma all-time high TTM net profit is -$2.76 M
What is Estrella Immunopharma TTM net income year-on-year change?
Over the past year, ESLAW TTM net profit has changed by -$5.93 M (-205.00%)